Management of malignant submandibular gland tumors: A 30-year experience from a single center
Autor: | Lukšić, Ivica, Mamić, Matija, Suton, Petar |
---|---|
Rok vydání: | 2022 |
Předmět: |
Submandibular Gland Neoplasms / diagnosis
Adenoma Pleomorphic / pathology Adenoma Pleomorphic Salivary Gland Neoplasms Carcinoma Adenoid Cystic Pathology and Forensic Medicine Submandibular Gland Neoplasms Salivary Gland Neoplasms / surgery Humans Carcinoma Adenoid Cystic / surgery Radiology Nuclear Medicine and imaging Dentistry (miscellaneous) Surgery Oral Surgery Salivary Gland Neoplasms / pathology Submandibular Gland Neoplasms / surgery Retrospective Studies |
Zdroj: | Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 134:302-309 |
ISSN: | 2212-4403 |
DOI: | 10.1016/j.oooo.2022.01.023 |
Popis: | Objective: Owing to histologic heterogeneity, biological behavior, and rarity, recommendations for the treatment of malignant submandibular gland tumors (MSGT) are inconsistent. The aim of this study was to present a single-center experience in the treatment of MSGT with an emphasis on surgical treatment, including indication on elective neck dissection (END). ----- Study design: Twenty-four MSGT were primary surgically treated (gland excision with neck dissection). Their records were retrospectively collected and analyzed. ----- Results: The most frequent histology was adenoid cystic carcinoma (41.6%), followed by mucoepidermoid carcinoma (25%) and carcinoma ex pleomorphic adenoma (16.7%). There were 18 elective and 6 therapeutic neck dissections. Histopathologic examination confirmed 29% (7/24) of positive neck dissection specimens. The Kaplan-Meier analysis presented rates of disease-specific survival, disease-free survival, and overall survival (OS) of 81%, 78%, and 52% at 5 years, respectively. Patients undergoing postoperative radiotherapy had significantly higher OS rates compared with patients treated with surgery alone (P = .0209). ----- Conclusion: Results of this study suggest that END has questionable benefit in early stage MSGT. Elective selective neck dissection levels I-III is recommended in high-grade and advanced stage MSGT without evidence of multilevel lymphadenopathy. |
Databáze: | OpenAIRE |
Externí odkaz: |